Yuxian Bai
Yuxian Bai publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Cancer Immunotherapy and Biomarkers.
- World rank
- #62,094 of 7,710,434 ranked researchers
- Rank in China
- #4,780 of 978,568
- Works
- 348
- Citations
- 20k
- Citations per work
- 57.6
What does Yuxian Bai research?
Yuxian Bai's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences24871.3%
- Medicine24871.3%
- Everything else6919.8%
- Life Sciences318.9%
- 1Oncology33% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Surgery12% of their works
- 4Hepatology5% of their works
- 5Molecular Biology5% of their works
- 6Cancer Research4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Esophageal Cancer Research and Treatment
- Lung Cancer Treatments and Mutations
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
Which keywords describe Yuxian Bai's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Clinical Practice Guidelines, Gastric Cancer, Molecular Characterization, Tumor Microenvironment, Cetuximab and KRAS Mutations.
- Surgical Complications
- Cholangiocarcinoma
- Liver Cancer
- Targeted Therapy
- Preoperative Chemoradiotherapy
- PD-1 and PD-L1
- Neoadjuvant Therapy
- KRAS Mutations
- Tumor Microenvironment
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Clinical Practice Guidelines
- Molecular Characterization
- Cetuximab
- Epidemiology
- Immune Checkpoint Blockade
- Esophageal Carcinoma
- EGFR Mutations
- Hepatocellular Carcinoma
- Biliary Tract Cancer
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy2483 topics
- Endoscopic Resection1712 topics
- Clinical Practice Guidelines1572 topics
- Gastric Cancer1161 topic
- Molecular Characterization1161 topic
- Tumor Microenvironment1122 topics
- Cetuximab971 topic
- KRAS Mutations971 topic
- Epidemiology912 topics
- Neoadjuvant Therapy902 topics
- Immune Checkpoint Blockade771 topic
- PD-1 and PD-L1771 topic
- Esophageal Carcinoma551 topic
- Preoperative Chemoradiotherapy551 topic
- EGFR Mutations431 topic
- Targeted Therapy431 topic
- Hepatocellular Carcinoma411 topic
- Liver Cancer411 topic
- Biliary Tract Cancer361 topic
- Cholangiocarcinoma361 topic
- Pancreatic Cancer351 topic
- Surgical Complications351 topic
Where does Yuxian Bai work?
Yuxian Bai's main affiliation in the publication record is Harbin Medical University, China.
How many publications and citations does Yuxian Bai have?
OpenAlex counts 348 works and 20,033 citations for Yuxian Bai, an h-index of 60, ranking #62,094 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yuxian Bai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.